Jeff Geschwind, MD – Innovator in Cancer Drug Development Founder of Cage Pharma, Jeff Geschwind, MD focuses on glycolysis-targeting cancer drugs, offering new hope for aggressive tumor treatments. https://pairs-society.org/academy_speakers/jeff-geschwind/